Helix Biopharma Corp
OTC:HBPCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Helix Biopharma Corp
OTC:HBPCF
|
CA |
|
A
|
ADM Hamburg AG
XHAM:OEL
|
DE |
|
A
|
Astron Paper & Board Mill Ltd
BSE:540824
|
IN |
|
Fuerte Metals Corp
TSX:TALA
|
CA |
|
International Frontier Resources Corp
OTC:IFRTF
|
CA |
|
O
|
Onelife Capital Advisors Ltd
BSE:533632
|
IN |
|
Q
|
Quantum eMotion Corp
OTC:QNCCF
|
CA |
|
A
|
Azbil Corp
XBER:YMK
|
JP |
|
Bong AB
F:20L
|
SE |
|
P
|
Panasonic Holdings Corp
XHAN:MAT1
|
JP |
|
Y
|
Yuexiu Real Estate Investment Trust
F:D3N
|
HK |
|
Dominion Lending Centres Inc
OTC:BRLGF
|
CA |
|
Nextleaf Solutions Ltd
F:L0MA
|
CA |
|
U
|
URA Holdings PLC
LSE:URAH
|
UK |
|
Cts Eventim AG & Co KgaA
OTC:CEVMF
|
DE |
|
S
|
Sunrise Resources Plc
SWB:S4D
|
UK |
|
B
|
Bumitama Agri Ltd
SWB:2BU
|
ID |
|
T
|
Tribe Technology PLC
LSE:TRYB
|
UK |
Bankruptcy Probability
Helix Biopharma Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Helix Biopharma Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Helix Biopharma Corp
TSX:HBP
|
124.5m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Helix Biopharma Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Helix Biopharma Corp has total debt of 359k CAD. This includes both short-term (359k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.
